MATINAS BIOPHARMA HOLDINGS, INC. Effective Tax Rate
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Effective Tax Rate of -0.07% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-31
- MATINAS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2025 was -0.07%, a 121.21% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.33%.
- MATINAS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- MATINAS BIOPHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|
| 2025-12-31 | -0.07% 10-K · filed 2026-03-31 |
| 2024-12-31 | 0.33% 10-K · filed 2026-03-31 |
| 2023-12-31 | 0.00% 10-K · filed 2025-04-15 |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-27 |
| 2021-12-31 | 0.00% 10-K · filed 2023-03-15 |
| 2020-12-31 | 0.00% 10-K/A · filed 2022-03-11 |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-29 |
| 2018-12-31 | 3.47% 10-K · filed 2020-03-09 |
| 2017-12-31 | 2.25% 10-K · filed 2019-04-01 |
| 2016-12-31 | 0.00% 10-K · filed 2018-03-16 |
| 2015-12-31 | 0.00% 10-K · filed 2017-03-31 |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-30 |
| 2013-12-31 | 0.00% 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |